Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling risk using generalized linear models.

D K Blough1, C W Madden, M C Hornbrook

  • 1University of Washington, Seattle, WA, USA.

Journal of Health Economics
|May 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of approaches for association studies of polymorphisms and colorectal cancer risk.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2012
Same author

Patterns of blood product use among patients with myelodysplastic syndrome.

Vox sanguinis·2011
Same author

Insurance coverage for erectile dysfunction drugs.

Clinical pharmacology and therapeutics·2010
Same author

Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis.

Clinical pharmacology and therapeutics·2009
Same author

Effectiveness and cost-effectiveness of echocardiography and carotid imaging in the management of stroke.

Evidence report/technology assessment (Summary)·2002
Same author

Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals.

Stroke·2001
Same journal

Competition matters: Uniform vs. indication-based pricing of pharmaceuticals.

Journal of health economics·2026
Same journal

Integrating equity and productivity in health evaluation.

Journal of health economics·2026
Same journal

Income and immunity: The consequences of social security administration reform for childhood infection risk.

Journal of health economics·2026
Same journal

When fewer children mean shorter lives: Fertility policy and elderly well-being in China.

Journal of health economics·2026
Same journal

Health dynamics and reporting bias at retirement: An analysis using high-frequency data.

Journal of health economics·2026
Same journal

Intertemporal coordination in volunteer markets.

Journal of health economics·2026
See all related articles

This study introduces advanced generalized linear models for predicting medical risk, offering a novel approach beyond traditional linear regression. The new methods improve risk prediction accuracy using maximum likelihood estimation and real-world healthcare data.

Area of Science:

  • Biostatistics
  • Health Economics
  • Medical Informatics

Background:

  • Linear regression is the standard for medical risk prediction.
  • Two-part models are commonly used for healthcare utilization and cost data.
  • Limitations exist in traditional methods for modeling complex healthcare data.

Purpose of the Study:

  • To present novel extensions of generalized linear models for the second part of two-part models.
  • To improve the accuracy and flexibility of medical risk prediction.
  • To provide an alternative to traditional linear regression in healthcare modeling.

Main Methods:

  • Utilizing extensions of the generalized linear model (GLM).
  • Employing maximum likelihood estimation (MLE) as the primary estimation method.

Related Experiment Videos

  • Discussing quasi-likelihood and extended quasi-likelihood generalizations.

    • Main Results:

    • The proposed GLM extensions effectively model the second part of two-part models.
    • Demonstrated application using medical expense data from Washington State employees.
    • Incorporated demographic variables and Ambulatory Care Group for enhanced prediction.

    Conclusions:

    • The extended GLM approach offers a powerful alternative for medical risk prediction.
    • This methodology enhances the modeling of healthcare utilization and costs.
    • The findings have implications for health economics and biostatistical modeling.